Remedica voluntarily recalls specific batches of Remethan anti-inflammatory medication

Coverage spans the spectrum: 25% left, 25% center, 50% right. Cross-spectrum coverage is a positive signal — the core facts are broadly accepted. Compare how each side headlines it to understand the editorial framing.